Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review

Diabetes/Metabolism Research and Reviews

Volumn 32, Issue , 2016, Pages 136-144

  Hinchliffe, R J ^a   Brownrigg, J R W ^a   Andros, G ^b   Apelqvist, J ^c   Boyko, E J ^d   Fitridge, R ^e   Mills, J L ^f   Reekers, J ^g   Shearman, C P ^h   Zierler, R E ⁱ   Schaper, N C ^j  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b Valley Presbyterian Hospital   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

ⁱ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^j MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Amputation; Diabetes; Diabetic foot; Peripheral artery disease; Ulcer

Indexed keywords

ANGIOPLASTY; ARTICLE; BYPASS SURGERY; CONSERVATIVE TREATMENT; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC PATIENT; END STAGE RENAL DISEASE; ENDOVASCULAR SURGERY; FOLLOW UP; FOOT ULCER; HUMAN; INFECTION; LEG REVASCULARIZATION; LIMB AMPUTATION; LIMB SALVAGE; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVASCULARIZATION; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; ULCER HEALING; ADVERSE EFFECTS; AMPUTATION; BLOOD VESSEL GRAFT; COMPLICATION; DIABETIC ANGIOPATHY; EVIDENCE BASED MEDICINE; EXPERIMENTAL THERAPY; FOOT; PERSONALIZED MEDICINE; TRENDS; VASCULARIZATION; WOUND HEALING;

AMPUTATION; ANGIOPLASTY; DIABETIC ANGIOPATHIES; DIABETIC FOOT; ENDOVASCULAR PROCEDURES; EVIDENCE-BASED MEDICINE; FOOT; HUMANS; LIMB SALVAGE; PRECISION MEDICINE; THERAPIES, INVESTIGATIONAL; VASCULAR GRAFTING; WOUND HEALING;

EID: 84956836392     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2705     Document Type: Article

References (93)

1. Hinchliffe RJ, Andros G, Apelqvist J, et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes Metab Res Rev 2012; 28(Suppl 1): 179-217.
2. IWGDF Guidance on the Diagnosis. Prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes.
3. Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on between individuals with and without peripheral vascular disease. The EURODIALE study. Diabetologia 2008; 51: 747-755.
4. Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 2000; 16(Suppl 1): S75-83.
5. Welborn TA, Knuiman M, McCann V, Stanton K, Constable IJ. Clinical macrovascular disease in Caucasoid diabetic subjects: logistic regression analysis of risk variables. Diabetologia 1984; 27: 568-573.
6. Walters DP, Gatling W, Mullee MA, Hill RD. The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community. Diabet Med 1992; 9: 710-715.
7. Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia 1995; 38: 86-96.
8. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003; 26(12): 3333-41.
9. Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007; 50: 18-25.
10. Jeffcoate WJ, Chipchase SY, Ince P, Game FL. Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care 2006; 29: 1784-7.
11. Beckert S, Witte M, Wicke C, Königsrainer A, Coerper S. A new wound-based severity score for diabetic foot ulcers. Diab Care 2006; 29: 988-992.
12. Dolan NC, Liu K, Criqui MH, et al. Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 2002; 25: 113-20.
13. Wattanakit K, Folsom AR, Selvin E, Coresh J, Hirsch AT, Weatherley BD. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. Am Soc Nephrol 2007; 18: 629-36.
14. Prompers L, Huijberts M, Apelqvist J, et al. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study. Diabet Med 2008; 25: 700-7.
15. Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care 2003; 26: 491-4.
16. Ruiter MS, van Golde JM, Schaper NC, Stehouwer CD, Huijberts MS. Diabetes impairs arteriogenesis in the peripheral circulation: review of molecular mechanisms. Clin Sci (Lond) 2010; 119(6): 225-38.
17. Graziani L, Silvestro A, Bertone V, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 2007; 33(4): 453-60.
18. Faglia E, Mantero M, Caminiti M, et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 2002; 252: 225-32.
19. Jacqueminet S, Hartemann-Heurtier A, Izzillo R, et al. Percutaneous transluminal angioplasty in severe diabetic foot ischemia: outcomes and prognostic factors. Diabetes Metab 2005; 31: 370-375.
20. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45(Suppl S): S5-S67.
21. Bollinger A, Breddin K, Hess H, et al. Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images. Atherosclerosis 1981; 38(3-4): 339-46.
22. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.
23. Scottish Intercollegiate Guidelines Network 50: a guideline developer's handbook. http://www.sign.ac.uk/guidelines/fulltext/50/section6.html. Accessed 6 February 2011.
24. AhChong AK, Chiu KM, Wong MW, Hui HK, Yip AW. Diabetes and the outcome of infrainguinal bypass for critical limb ischaemia. ANZ J Surg 2004; 74(3): 129-33.
25. Alexandrescu V, Hubermont G, Philips Y, et al. Combined primary subintimal and endoluminal angioplasty for ischaemic inferior-limb ulcers in diabetic patients: 5-year practice in a multidisciplinary 'diabetic-foot' service. Eur J Vasc Endovasc Surg 2009 Apr 37(4): 448-56.
26. Bargellini I, Petruzzi P, Scatena A, et al. Primary infrainguinal subintimal angioplasty in diabetic patients. Cardiovasc Intervent Radiol 2008; 31(4): 713-22.
27. Davidson JT 3rd, Callis JT. Arterial reconstruction of vessels in the foot and ankle. Ann Surg 1993; 217(6): 699-708.
28. Dosluoglu HH, Cherr GS, Lall P, Harris LM, Dryjski ML. Peroneal artery-only runoff following endovascular revascularizations is effective for limb salvage in patients with tissue loss. J Vasc Surg 2008; 48(1): 137-43.
29. Dorweiler B, Neufang A, Schmiedt W, Oelert H. Pedal arterial bypass for limb salvage in patients with diabetes mellitus. Eur J Vasc Endovasc Surg 2002; 24(4): 309-13.
30. Faglia E, Dalla Paola L, Clerici G, et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg 2005; 29(6): 620-7.
31. Faglia E, Clerici G, Clerissi J, et al. Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study. Diabetes Care 2009; 32(5): 822-7.
32. Ferraresi R, Centola M, Ferlini M, et al. Long-term outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia. Eur J Vasc Endovasc Surg 2009; 37(3): 336-42.
33. Gargiulo M, Maioli F, Ceccacci T, et al. What's next after optimal infrapopliteal angioplasty? Clinical and ultrasonographic results of a prospective single-center study. J Endovasc Ther 2008; 15(3): 363-9.
34. Gibbons GW, Burgess AM, Guadagnoli E, et al. Return to well-being and function after infrainguinal revascularization. J Vasc Surg 1995; 21(1): 35-44.
35. Hering J, Angelkort B, Keck N, Wilde J, Amann B. Long-term outcome of successful percutaneous transluminal angioplasty of the fibular artery in diabetic foot syndrome and single-vessel calf perfusion depends on doppler wave pattern at the forefoot. Vasa 2010; 39: 67-75.
36. Hertzer NR, Bena JF, Karafa MT. A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease. J Vasc Surg 2007; 46(2): 271-279.
37. Hughes K, Domenig CM, Hamdan AD, et al. Bypass to plantar and tarsal arteries: an acceptable approach to limb salvage. J Vasc Surg 2004; 40(6): 1149-57.
38. Isaksson L, Lundgren F. Prognostic factors for failure of primary patency within a year of bypass to the foot in patients with diabetes and critical ischaemia. Eur J Surg 2000; 166(2): 123-8.
39. Jämsén T, Manninen H, Tulla H, Matsi P. The final outcome of primary infrainguinal percutaneous transluminal angioplasty in 100 consecutive patients with chronic critical limb ischemia. J Vasc Interv Radiol 2002; 13(5): 455-63.
40. Johnson BL, Glickman MH, Bandyk DF, Esses GE. Failure of foot salvage in patients with end-stage renal disease after surgical revascularization. J Vasc Surg 1995; 22(3): 280-5.
41. Kalra M, Gloviczki P, Bower TC, et al. Limb salvage after successful pedal bypass grafting is associated with improved long-term survival. J Vasc Surg 2001; 33(1): 6-16.
42. Kandzari DE, Kiesz RS, Allie D, et al. Procedural and clinical outcomes with catheter-based plaque excision in critical limb ischemia. J Endovasc Ther 2006; 13(1): 12-22.
43. Leers SA, Reifsnyder T, Delmonte R, Caron M. Realistic expectations for pedal bypass grafts in patients with end-stage renal disease. J Vasc Surg 1998; 28(6): 976-80.
44. Malmstedt J, Leander K, Wahlberg E, Karlström L, Alfredsson L, Swedenborg J. Outcome after leg bypass surgery for critical limb ischemia is poor in patients with diabetes: a population-based cohort study. Diabetes Care 2008; 31(5): 887-92.
45. Mills JL, Gahtan V, Fujitani RM, Taylor SM, Bandyk DF. The utility and durability of vein bypass grafts originating from the popliteal artery for limb salvage. Am J Surg 1994; 168(6): 646-50.
46. Mohan CR, Hoballah JJ, Martinasevic M, et al. Revascularization of the ischemic diabetic foot using popliteal artery inflow. Int Angiol 1996; 15(2): 138-43.
47. Owens CD, Ho KJ, Kim S, et al. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg 2007; 45(5): 944-52.
48. Panneton JM, Gloviczki P, Bower TC, Rhodes JM, Canton LG, Toomey BJ. Pedal bypass for limb salvage: impact of diabetes on long-term outcome. Ann Vasc Surg 2000; 14(6): 640-7.
49. Pomposelli FB Jr, Marcaccio EJ, Gibbons GW, et al. Dorsalis pedis arterial bypass: durable limb salvage for foot ischemia in patients with diabetes mellitus. J Vasc Surg 1995; 21(3): 375-84.
50. Pomposelli FB, Kansal N, Hamdan AD, et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 2003; 37(2): 307-15.
51. Pua U, Wong DE. Angioplasty in critical limb ischaemia: one-year limb salvage results. Ann Acad Med Singapore 2008; 37(3): 224-9.
52. Ramdev P, Rayan SS, Sheahan M, et al. A decade experience with infrainguinal revascularization in a dialysis-dependent patient population. J Vasc Surg 2002; 36(5): 969-74.
53. Reed AB, Conte MS, Belkin M, Mannick JA, Whittemore AD, Donaldson MC. Usefulness of autogenous bypass grafts originating distal to the groin. J Vasc Surg 2002; 35(1): 48-54.
54. Rosenblum BI, Pomposelli FB Jr, Giurini JM, et al. Maximizing foot salvage by a combined approach to foot ischemia and neuropathic ulceration in patients with diabetes. A 5-year experience. Diabetes Care 1994; 17(9): 983-7.
55. Saltzberg SS, Pomposelli FB Jr, Belfield AK, et al. Outcome of lower-extremity revascularization in patients younger than 40 years in a predominantly diabetic population. J Vasc Surg 2003; 38(5): 1056-9.
56. Schneider JR, Walsh DB, McDaniel MD, Zwolak RM, Besso SR, Cronenwett JL. Pedal bypass versus tibial bypass with autogenous vein: a comparison of outcome and hemodynamic results. J Vasc Surg 1993; 17(6): 1029-38.
57. Schneider PA, Caps MT, Ogawa DY, Hayman ES. Intraoperative superficial femoral artery balloon angioplasty and popliteal to distal bypass graft: an option for combined open and endovascular treatment of diabetic gangrene. J Vasc Surg 2001; 33(5): 955-62.
58. Sigala F, Georgopoulos S, Langer S, et al. Outcome of infrainguinal revascularization for critical limb ischemia in diabetics with end stage renal disease. Vasa 2006; 35(1): 15-20.
59. Söderström M, Arvela E, Albäck A, Aho PS, Lepäntalo M. Healing of ischaemic tissue lesions after infrainguinal bypass surgery for critical leg ischaemia. Eur J Vasc Endovasc Surg 2008; 36(1): 90-5.
60. Stonebridge PA, Tsoukas AI, Pomposelli FB Jr, et al. Popliteal-to-distal bypass grafts for limb salvage in diabetics. Eur J Vasc Surg 1991; 5(3): 265-9.
61. Tannenbaum GA, Pomposelli FB Jr, Marcaccio EJ, et al. Safety of vein bypass grafting to the dorsal pedal artery in diabetic patients with foot infections. J Vasc Surg 1992; 15(6): 982-8.
62. Taylor LM Jr, Porter JM. The clinical course of diabetics who require emergent foot surgery because of infection or ischemia. J Vasc Surg 1987; 6(5): 454-9.
63. Toursarkissian B, Stefanidis D, Hagino RT, et al. Early duplex-derived hemodynamic parameters after lower extremity bypass in diabetics: implications for mid-term outcomes. Ann Vasc Surg 2002; 16(5): 601-7.
64. Toursarkissian B, Jones WT, D'Ayala MD, et al. Does the efficacy of dorsalis pedis artery bypasses vary among diabetic patients of different ethnic backgrounds? Vasc Endovascular Surg 2002; 36(3): 207-12.
65. Uccioli L, Gandini R, Giurato L, et al. Long-term outcomes of diabetic patients with critical limb ischaemia followed in a tertiary referral diabetic foot clinic. Diabetes Care 2010; 33(5): 977-82.
66. Verhelst R, Bruneau M, Nicolas AL, et al. Popliteal-to-distal bypass grafts for limb salvage. Ann Vasc Surg 1997; 11(5): 505-9.
67. Werneck CC, Lindsay TF. Tibial angioplasty for limb salvage in high-risk patients and cost analysis. Ann Vasc Surg 2009; 23(5): 554-9.
68. Woelfle KD, Lange G, Mayer H, Bruijnen H, Loeprecht H. Distal vein graft reconstruction for isolated tibioperoneal vessel occlusive disease in diabetics with critical foot ischaemia-does it work? Eur J Vasc Surg 1993; 7(4): 409-13.
69. Wölfle KD, Bruijnen H, Reeps C, et al. Tibioperoneal arterial lesions and critical foot ischaemia: successful management by the use of short vein grafts and percutaneous transluminal angioplasty. Vasa 2000; 29(3): 207-14.
70. Woelfle KD, Bruijnen H, Loeprecht H. Infrapopliteal arterial occlusive disease in diabetics with critical foot ischaemia: the role of distal origin bypass grafts. Vasa 2001; 30(Suppl.58): 40-43.
71. Zayed H, Halawa M, Maillardet L, Sidhu PS, Edmonds M, Rashid H. Improving limb salvage rate in diabetic patients with critical leg ischaemia using a multidisciplinary approach. Int J Clin Pract 2009; 63(6): 855-8.
72. Rigatelli G, Cardaioli P, Dell'avvocata F, Giordan M, Lisato G, Mollo F. Endovascular management of patients with coronary artery disease and diabetic foot syndrome: a long-term follow-up. J Geriatr Cardiol 2011; 8: 78-81.
73. Park SW, Kim JS, Yun IJ, et al. Clinical outcomes of endovascular treatments for critical limb ischemia with chronic total occlusive lesions limited to below-the-knee arteries. Acta Radiol 2013; 54: 785-9.
74. Lejay A, Georg Y, Tartaglia E, et al. Long-term outcomes of direct and indirect below-the-knee open revascularization based on the angiosome concept in diabetic patients with critical limb ischemia. Ann Vasc Surg 2014; 28: 983-9.
75. Acín F, Varela C, López de Maturana I, de Haro J, Bleda S, Rodriguez-Padilla J. Results of infrapopliteal endovascular procedures performed in diabetic patients with critical limb ischemia and tissue loss from the perspective of an angiosome-oriented revascularization strategy. Int J Vasc Med 2014; 2014: 270539.
76. Söderström M1, Albäck A, Biancari F, Lappalainen K, Lepäntalo M, Venermo M. Angiosome-targeted infrapopliteal endovascular revascularization for treatment of diabetic foot ulcers. J Vasc Surg 2013; 57: 427-35.
77. Kabra A, Suresh KR, Vivekanand V, Vishnu M, Sumanth R, Nekkanti M. Outcomes of angiosome and non-angiosome targeted revascularization in critical lower limb ischemia. J Vasc Surg 2013; 57: 44-9.
78. Zhan LX, Bharara M, White M, et al. Comparison of initial hemodynamic response after endovascular therapy and open surgical bypass in patients with diabetes mellitus and critical limb ischemia. J Vasc Surg 2012; 56: 380-6.
79. Alexandrescu V, Vincent G, Azdad K, et al. A reliable approach to diabetic neuroischemic foot wounds: below-the-knee angiosome-oriented angioplasty. J Endovasc Ther 2011; 18: 376-87.
80. Alexandrescu VA. Commentary: myths and proofs of angiosome applications in CLI: where do we stand? J Endovasc Ther 2014: 616-24.
81. Gershater MA, Löndahl M, Nyberg P, et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia 2009; 52(3): 398-407.
82. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 1998; 21(5): 855-9.
83. LoGerfo FW, Coffman JD. Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 1984; 311(25): 1615-9.
84. Lepäntalo M, Mätzke S. Outcome of unreconstructed chronic critical leg ischaemia. Eur J Vasc Endovasc Surg 1996; 11(2): 153-7.
85. Elgzyri T, Larsson J, Thörne J, Eriksson KF, Apelqvist J. Outcome of ischemic foot ulcer in diabetic patients who had no invasive vascular intervention. Eur J Vasc Endovasc Surg 2013; 46: 110-7.
86. Albers M, Romiti M, Brochado-Neto FC, De Luccia N, Pereira CA. Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg 2006; 43(3): 498-503.
87. Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008; 47(5): 975-981.
88. Biancari F, Juvonen T. Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2014; 47: 517-22.
89. Sumpio BE, Forsythe RO, Ziegler KR, van Baal JG, Lepantalo MJ, Hinchliffe RJ. Clinical implications of the angiosome model in peripheral vascular disease. J Vasc Surg 2013; 58: 814-26.
90. Kagaya Y, Ohura N, Suga H, Eto H, Takushima A, Harii K. 'Real angiosome' assessment from peripheral tissue perfusion using tissue oxygen saturation foot-mapping in patients with critical limb ischemia. Eur J Vasc Endovasc Surg 2014; 47: 433-41.
91. Ndip A, Lavery LA, Boulton AJ. Diabetic foot disease in people with advanced nephropathy and those on renal dialysis. Curr Diab Rep 2010; 10(4): 283-90.
92. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26(3): 517-38.
93. Karthikesalingam A, Holt PJ, Moxey P, Jones KG, Thompson MM, Hinchliffe RJ. A systematic review of scoring systems for diabetic foot ulcers. Diabet Med 2010; 27(5): 544-9.